| Info: | Warfarin |
| PubMed: | Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. |
| PubMed: | Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy. |
| PubMed: | Long term oral anticoagulant therapy with warfarin: experience with local patient population in kuwait. |
| PubMed: | Edoxaban: a focused review of its clinical pharmacology. |
| PubMed: | Beyond warfarin: A patient-centered approach to selecting novel oral anticoagulants for stroke prevention in atrial fibrillation. |
| PubMed: | Evaluation of the biointeraction of colorant flavazin with human serum albumin: insights from multiple spectroscopic studies, in silico docking and molecular dynamics simulation. |
| PubMed: | Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects. |
| PubMed: | The Role of Rivaroxaban in Atrial Fibrillation and Acute Coronary Syndromes. |
| PubMed: | [New treatments for stroke and thromboembolism prevention in atrial fibrillation]. |
| PubMed: | Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population. |
| PubMed: | New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions. |
| PubMed: | Bioavailability and activity of natural food additive triterpenoids as influenced by protein. |
| PubMed: | Ensuring medication adherence with direct oral anticoagulant drugs: Lessons from adherence with vitamin K antagonists (VKAs). |
| PubMed: | Evaluating warfarin management by pharmacists in a community teaching hospital. |
| PubMed: | Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. |
| PubMed: | Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis. |
| PubMed: | Emergency department management of patients on novel oral anticoagulant agents. |
| PubMed: | [Efficacy and safety of apixaban compared with warfarin regarding time within the therapeutic range]. |
| PubMed: | Alternative to oral dicoumarin anticoagulants: Considerations in dental care. |
| PubMed: | New Oral Anticoagulants in Practice: Pharmacological and Practical Considerations. |
| PubMed: | Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions. |
| PubMed: | The new era of anticoagulation. |
| PubMed: | Competitive interactions of anti-carcinogens with serum albumin: a spectroscopic study of bendamustine and dexamethasone with the aid of chemometrics. |
| PubMed: | Determination of bioequivalence for drugs with narrow therapeutic index: reduction of the regulatory burden. |
| PubMed: | Local verification and assignment of mean normal prothrombin time and International Sensitivity Index values across various instruments: recent experience and outcome from North America. |
| PubMed: | Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus. |
| PubMed: | Cost-effectiveness analysis of intracranial stent placement versus contemporary medical management in patients with symptomatic intracranial artery stenosis. |
| PubMed: | Betrixaban (PRT054021): pharmacology, dose selection and clinical studies. |
| PubMed: | Deep vein thrombosis and novel oral anticoagulants: a clinical review. |
| PubMed: | Pharmacogenetics and coumarin dosing--recalibrating expectations. |
| PubMed: | Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries. |
| PubMed: | A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran. |
| PubMed: | Novel oral anticoagulants for stroke prevention in the geriatric population. |
| PubMed: | Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy. |
| PubMed: | Cost implications of formulary decisions on oral anticoagulants in nonvalvular atrial fibrillation. |
| PubMed: | Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic. |
| PubMed: | Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary. |
| PubMed: | Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation. |
| PubMed: | Advantages and limitations of the new anticoagulants. |
| PubMed: | Genetics-based pediatric warfarin dosage regimen derived using pharmacometric bridging. |
| PubMed: | Drug adherence in patients taking oral anticoagulation therapy. |
| PubMed: | Balancing efficacy and bleeding risk in the prevention of stroke due to atrial fibrillation with newer oral anticoagulants. |
| PubMed: | Antithrombotic therapy for pregnant women. |
| PubMed: | Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives. |
| PubMed: | Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery. |
| PubMed: | The promise of pharmacoepidemiology in helping clinicians assess drug risk. |
| PubMed: | Novel oral anticoagulants: a review of new agents. |
| PubMed: | Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey. |
| PubMed: | Apixaban in the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation. |
| PubMed: | New alternative anticoagulants in atrial fibrillation: the move beyond warfarin. |
| PubMed: | Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation. |
| PubMed: | The changing face of oral anticoagulants. |
| PubMed: | Kcentra: a 4-factor prothrombin complex concentrate for reversal of warfarin anticoagulation. |
| PubMed: | Data mining of the public version of the FDA Adverse Event Reporting System. |
| PubMed: | Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation. |
| PubMed: | [Anticoagulation in atrial fibrillation: new therapeutic alternatives]. |
| PubMed: | Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin. |
| PubMed: | European cardiac nurses' current practice and knowledge on anticoagulation therapy. |
| PubMed: | Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient. |
| PubMed: | Updated guidelines on outpatient anticoagulation. |
| PubMed: | The safety and efficacy of apixaban : where do we stand in 2013? |
| PubMed: | [The change of paradigm in stroke prevention in atrial fibrillation. Challenges and emerging opportunities for the family physician]. |
| PubMed: | [Direct oral thrombin inhibitor, "dabigatran"]. |
| PubMed: | One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events. |
| PubMed: | Anticoagulation for non-valvular atrial fibrillation: new anticoagulant agents. |
| PubMed: | [ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants]. |
| PubMed: | Rivaroxaban for the treatment of acute coronary syndromes. |
| PubMed: | Characteristics and essences upon conjugation of imidacloprid with two model proteins. |
| PubMed: | Tutorial in oral antithrombotic therapy: biology and dental implications. |
| PubMed: | Stroke prevention in atrial fibrillation--an Asian stroke perspective. |
| PubMed: | Left atrial appendage closure devices. Their role in 2013. |
| PubMed: | Dabigatran and postmarketing reports of bleeding. |
| PubMed: | A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice. |
| PubMed: | Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation. |
| PubMed: | Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation. |
| PubMed: | Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation. |
| PubMed: | Novel oral anticoagulants: a review of the literature and considerations in special clinical situations. |
| PubMed: | The discovery of dabigatran etexilate. |
| PubMed: | Antithrombotics for stroke prevention in non-valvular atrial fibrillation: an update. |
| PubMed: | Rash associated with dabigatran etexilate. |
| PubMed: | The pharmacology and therapeutic use of dabigatran etexilate. |
| PubMed: | Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era. |
| PubMed: | Medication dyes as a source of drug allergy. |
| PubMed: | Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians. |
| PubMed: | New oral anticoagulants in elderly patients with atrial fibrillation. |
| PubMed: | [Dabigatran as an alternative to warfarin for the prevention of thromboembolism in atrial fibrillation]. |
| PubMed: | Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs. |
| PubMed: | Anticoagulant prevention in patients with atrial fibrillation: alternatives to vitamin K antagonists. |
| PubMed: | Role of new drugs for management of atrial fibrillation. |
| PubMed: | Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"? |
| PubMed: | Transitions of care in patients receiving oral anticoagulants: general principles, procedures, and impact of new oral anticoagulants. |
| PubMed: | Dabigatran: a cause of hematologic emergency. |
| PubMed: | Comparing new anticoagulants. |
| PubMed: | An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs. |
| PubMed: | [Dabigatran etexilate in clinical practice for prevention of thromboembolic events in patients with atrial fibrillation]. |
| PubMed: | Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong. |
| PubMed: | Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). |
| PubMed: | The new oral anticoagulants: a challenge for hospital formularies. |
| PubMed: | Target-specific oral anticoagulants for stroke prevention in patients with atrial fibrillation: real-world considerations. |
| PubMed: | Stroke prevention in atrial fibrillation: impact of novel oral anticoagulants. |
| PubMed: | New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function. |
| PubMed: | Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. |
| PubMed: | Management of oral anticoagulation in patients undergoing minor dental procedures. |
| PubMed: | Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation. |
| PubMed: | Enantioselective binding interaction of the metolachlor pesticide enatiomers with bovine serum albumin--a spectroscopic analysis study. |
| PubMed: | Botanical-drug interactions: a scientific perspective. |
| PubMed: | Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS. |
| PubMed: | Safety and efficacy of apixaban in the treatment of atrial fibrillation. |
| PubMed: | Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges. |
| PubMed: | An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation. |
| PubMed: | Complications of anticoagulation. |
| PubMed: | Emergency management of bleeding associated with old and new oral anticoagulants. |
| PubMed: | Antithrombotic therapy for secondary stroke prevention. |
| PubMed: | Fatal gastrointestinal hemorrhage after a single dose of dabigatran. |
| PubMed: | Hemopericardium and cardiac tamponade associated with dabigatran use. |
| PubMed: | [Apixaban]. |
| PubMed: | Bioevaluation of human serum albumin-hesperidin bioconjugate: insight into protein vector function and conformation. |
| PubMed: | Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin? |
| PubMed: | Rapid LC-MS/MS determination and pharmacokinetic application of linarin in rat plasma. |
| PubMed: | New oral anticoagulants: will they replace warfarin? |
| PubMed: | Jonathan E. Rhoads lecture 2012: improving patient care with practice-based research. |
| PubMed: | Multispectroscopic and molecular modeling approach to investigate the interaction of flavokawain B with human serum albumin. |
| PubMed: | Development and validation of LC-MS/MS method for the estimation of β-hydroxy-β-methylbutyrate in rat plasma and its application to pharmacokinetic studies. |
| PubMed: | A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation. |
| PubMed: | Clinical pharmacokinetics and pharmacodynamics of linagliptin. |
| PubMed: | Evaluation of food-drug interaction of guava leaf tea. |
| PubMed: | Oral IIa and Xa inhibitors for prevention of stroke in atrial fibrillation: clinical studies and regulatory considerations. |
| PubMed: | [Old and new oral anticoagulants. Pharmacological perspective]. |
| PubMed: | [Possible interaction between pomegranate juice and warfarin]. |
| PubMed: | New anticoagulants in ischemic heart disease. |
| PubMed: | Vitamin K nutrition, metabolism, and requirements: current concepts and future research. |
| PubMed: | Implementing the new oral anticoagulants into the hospital formulary. |
| PubMed: | The Efficacy of Rivaroxaban in Patients With Atrial Fibrillation. |
| PubMed: | Dabigatran: a new chapter in anticoagulation. |
| PubMed: | Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. |
| PubMed: | Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis. |
| PubMed: | Novel drugs for oral anticoagulation pharmacotherapy. |
| PubMed: | Biophysical influence of isocarbophos on bovine serum albumin: spectroscopic probing. |
| PubMed: | Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders. |
| PubMed: | Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial. |
| PubMed: | Successful management of anticoagulation therapy during international travel. |
| PubMed: | Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use. |
| PubMed: | Newer anticoagulants in cardiovascular disease: a systematic review of the literature. |
| PubMed: | Identification of cytochrome P450 2D6 and 2C9 substrates and inhibitors by QSAR analysis. |
| PubMed: | Epidural hematoma and intraoperative hemorrhage in a spine trauma patient on Pradaxa (dabigatran). |
| PubMed: | Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats. |
| PubMed: | Clinical pharmacokinetics and pharmacodynamics of vildagliptin. |
| PubMed: | I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different? |
| PubMed: | Apixaban for the prevention of stroke in atrial fibrillation. |
| PubMed: | Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. |
| PubMed: | New frontiers for stroke prevention in atrial fibrillation. |
| PubMed: | Heparin-induced thrombocytopenia. |
| PubMed: | Cranberry and warfarin interaction: a case report and review of the literature. |
| PubMed: | Newer anticoagulants for non-valvular atrial fibrillation. |
| PubMed: | Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies. |
| PubMed: | Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation. |
| PubMed: | Rivaroxaban (Xarelto) for acute coronary syndrome. |
| PubMed: | Dabigatran etexilate: what do hospitalists need to know? |
| PubMed: | Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. |
| PubMed: | FDA advisory decision highlights some problems inherent in pragmatic trials. |
| PubMed: | Single-walled carbon nanotubes based quenching of free FAM-aptamer for selective determination of ochratoxin A. |
| PubMed: | Dietary interactions and INR variability: retrospective evaluation of patients couples on oral anticoagulant therapy. |
| PubMed: | Competitive binding of small molecules with biopolymers: a fluorescence spectroscopy and chemometrics study of the interaction of aspirin and ibuprofen with BSA. |
| PubMed: | What risk do consumers face when seeking medical advice from health food stores? |
| PubMed: | Multivariate analysis of the relation between diet and warfarin dose. |
| PubMed: | Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. |
| PubMed: | New anticoagulants for the prevention of stroke in atrial fibrillation. |
| PubMed: | Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice. |
| PubMed: | Warfarin resistance and caffeine containing beverages. |
| PubMed: | Mechanism and conformational studies of farrerol binding to bovine serum albumin by spectroscopic methods. |
| PubMed: | Anticoagulant management in the cardiovascular setting. |
| PubMed: | Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem? |
| PubMed: | Buyer beware? Does the information provided with herbal products available over the counter enable safe use? |
| PubMed: | Old versus new oral anticoagulants: focus on pharmacology. |
| PubMed: | Update on anti-coagulation in atrial fibrillation. |
| PubMed: | Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa. |
| PubMed: | Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation. |
| PubMed: | Dabigatran in atrial fibrillation: pharmacology and clinical trials. |
| PubMed: | The quality of information on websites selling St. John's wort. |
| PubMed: | New oral anticoagulants for venous thromboembolism prophylaxis in orthopaedic surgery. |
| PubMed: | What is the state of the art in orthopaedic thromboprophylaxis in lower extremity reconstruction? |
| PubMed: | Spotlight on dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation. |
| PubMed: | Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease. |
| PubMed: | New oral anticoagulants and outpatient prophylaxis of venous thromboembolism. |
| PubMed: | New options for stroke prevention in atrial fibrillation. |
| PubMed: | Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran. |
| PubMed: | Incidental atrial fibrillation and its management. |
| PubMed: | Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin. |
| PubMed: | New drug offers warfarin alternative for atrial fibrillation. An immediate switch is right for some people, but not necessary for all. |
| PubMed: | Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. |
| PubMed: | Thromboembolism. |
| PubMed: | Warfarin-cranberry juice interaction. |
| PubMed: | Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. |
| PubMed: | New oral anticoagulants. |
| PubMed: | Case report: Cranberry juice and warfarin. |
| PubMed: | Genetic warfarin dosing: tables versus algorithms. |
| PubMed: | Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation. |
| PubMed: | Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism. |
| PubMed: | New alternative to warfarin may help reduce stroke risk in patients with AF. |
| PubMed: | Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats. |
| PubMed: | Role of cytochrome P450 genotype in the steps toward personalized drug therapy. |
| PubMed: | Dabigatran emerges as safe and effective warfarin alternative. The recently approved drug is more expensive, but appears to be more predictable. |
| PubMed: | A potential interaction between warfarin and atovaquone. |
| PubMed: | The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. |
| PubMed: | Spectrophotometric study of the interaction between chlorotetracycline and bovine serum albumin using Eosin Y as site marker with the aid of chemometrics. |
| PubMed: | Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs. |
| PubMed: | Is it OK to drink cranberry juice if I take Coumadin? |
| PubMed: | A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. |
| PubMed: | Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrel. |
| PubMed: | Evaluation of the effect of lime fruit juice on the anticoagulant effect of warfarin. |
| PubMed: | My wife and I both take warfarin because we have atrial fibrillation. We've been told to stay away from green vegetables, because they are high in vitamin K. Is there a guideline for a "safe" amount to eat? |
| PubMed: | Personalized approaches to clopidogrel therapy: are we there yet? |
| PubMed: | Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). |
| PubMed: | [Fifty years of clinical use of warfarin]. |
| PubMed: | Stroke in atrial fibrillation--hope on the horizon? |
| PubMed: | New oral antithrombotic agents for the prevention of deep venous thrombosis and pulmonary embolism in orthopedic surgery. |
| PubMed: | Warfarin genotyping using three different platforms. |
| PubMed: | Cutting through the statistical fog: understanding and evaluating non-inferiority trials. |
| PubMed: | Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin. |
| PubMed: | Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin. |
| PubMed: | Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. |
| PubMed: | Sprouting a warfarin interaction. |
| PubMed: | Alternatives to warfarin--the next generation of anticoagulants. |
| PubMed: | Oral direct factor Xa inhibitors, with special emphasis on rivaroxaban. |
| PubMed: | Drug and dietary interactions of the new and emerging oral anticoagulants. |
| PubMed: | Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin. |
| PubMed: | Analysis of the interactions of mixtures of two beta-agonists steroids with bovine serum albumin: a fluorescence spectroscopy and chemometrics investigation. |
| PubMed: | Discharge teaching about warfarin: patient retention of knowledge. |
| PubMed: | Achievement of therapeutic international normalized ratio following adjustment of tube feeds. |
| PubMed: | Important drug-nutrient interactions. |
| PubMed: | Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. |
| PubMed: | Warfarin bioavailability with feeding tubes and enteral formula. |
| PubMed: | Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation. |
| PubMed: | [Possible interaction between probiotics and warfarin]. |
| PubMed: | Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation? |
| PubMed: | Pharmacogenomics: bridging the gap between science and practice. |
| PubMed: | New approaches to atrial fibrillation management: treat the patient, not the ECG. |
| PubMed: | Venous thromboembolism: a clinical review. |
| PubMed: | [Marked PT-INR prolongation associated with appetite loss due to urinary tract infection in a late elderly case with chronic atrial fibrillation]. |
| PubMed: | Potential interaction between MonaVie Active and Warfarin. |
| PubMed: | Non ST-elevation acute coronary syndrome. |
| PubMed: | Probable warfarin interaction with menthol cough drops. |
| PubMed: | Possible interaction between pomegranate juice and warfarin. |
| PubMed: | Vitamin K in parenteral nutrition. |
| PubMed: | Interactions between quercetin and warfarin for albumin binding: A new eye on food/drug interference. |
| PubMed: | Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. |
| PubMed: | Comment: fatal intracranial bleed potentially due to a warfarin and influenza vaccine interaction. |
| PubMed: | Anticoagulant rodenticides in three owl species from Western Canada, 1988-2003. |
| PubMed: | Patient time requirements for anticoagulation therapy with warfarin. |
| PubMed: | The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation. |
| PubMed: | Should we be applying warfarin pharmacogenetics to clinical practice? No, not now. |
| PubMed: | Potential interaction between pomegranate juice and warfarin. |
| PubMed: | Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. |
| PubMed: | Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy. |
| PubMed: | The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. |
| PubMed: | Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change. |
| PubMed: | Comparison of performance of three commercial platforms for warfarin sensitivity genotyping. |
| PubMed: | Acute coronary syndrome (unstable angina and non-ST elevation MI). |
| PubMed: | Thromboembolism. |
| PubMed: | Chiral toxicology: it's the same thing...only different. |
| PubMed: | Erythrocyte folate and 5-methyltetrahydrofolate levels decline during 6 months of oral anticoagulation with warfarin. |
| PubMed: | Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence? |
| PubMed: | Simultaneous determination of nonnutritive sweeteners in foods by HPLC/ESI-MS. |
| PubMed: | Cardiology patient pages. A patient's guide to taking coumadin/warfarin. |
| PubMed: | Equine cytochrome P450 2C92: cDNA cloning, expression and initial characterization. |
| PubMed: | Novel oral anticoagulants. |
| PubMed: | A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity. |
| PubMed: | Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. |
| PubMed: | Interaction between warfarin and black tea. |
| PubMed: | [Nonoclusive thrombosis of mechanical mitral valve prosthesis caused by inadequate treatment of anticoagulant therapy resistance]. |
| PubMed: | [Warfarin resistance and related pharmacogenetic information]. |
| PubMed: | Pharmacogenetic testing for warfarin sensitivity. |
| PubMed: | Overview of pharmacogenetics in anticoagulation therapy. |
| PubMed: | Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin. |
| PubMed: | Medication administration through enteral feeding tubes. |
| PubMed: | Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin. |
| PubMed: | Determination of ochratoxin a with a DNA aptamer. |
| PubMed: | Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer. |
| PubMed: | Role of ambrisentan in the management of pulmonary hypertension. |
| PubMed: | Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases. |
| PubMed: | Warfarin resistance. |
| PubMed: | Spectrometric and voltammetric studies of the interaction between quercetin and bovine serum albumin using warfarin as site marker with the aid of chemometrics. |
| PubMed: | The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics. |
| PubMed: | Clinically relevant safety issues associated with St. John's wort product labels. |
| PubMed: | [Factors influencing activity of oral anticoagulants. Interactions with drugs and food]. |
| PubMed: | Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin. |
| PubMed: | Patient knowledge on oral anticoagulants: results of a questionnaire survey in Germany and comparison with the literature. |
| PubMed: | Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? |
| PubMed: | Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet? |
| PubMed: | Advancement in antithrombotics for stroke prevention in atrial fibrillation. |
| PubMed: | Survival of heparins, oral anticoagulants, and aspirin after the year 2010. |
| PubMed: | Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. |
| PubMed: | Potential interaction between warfarin and high dietary protein intake. |
| PubMed: | Practical aspects of treatment with drotrecogin alfa (activated). |
| PubMed: | Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. |
| PubMed: | Warfarin overdose due to the possible effects of Lycium barbarum L. |
| PubMed: | Cranberry juice and warfarin: okay together? |
| PubMed: | Recent developments in antithrombotic therapy: will sodium warfarin be a drug of the past? |
| PubMed: | Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? |
| PubMed: | The FDA announces new drug labeling for pharmacogenetic testing: is personalized medicine becoming a reality? |
| PubMed: | Factors influencing warfarin dose requirements in African-Americans. |
| PubMed: | Vitamin K: what are the current dietary recommendations for patients taking coumadin? |
| PubMed: | Anticoagulant effect of sodium dehydroacetate (DHA-S) in rats. |
| PubMed: | Interaction between warfarin and cranberry juice. |
| PubMed: | Garlic (Allium sativum L.): adverse effects and drug interactions in humans. |
| PubMed: | Pharmacogenomics and warfarin therapy. |
| PubMed: | The new anticoagulants. |
| PubMed: | Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. |
| PubMed: | Outpatient-based primary and secondary thromboprophylaxis with low-molecular-weight heparin. |
| PubMed: | FDA encourages genetics-aided warfarin dosing. |
| PubMed: | Changing times: DNA resequencing and the "nearly normal autopsy". |
| PubMed: | [Advice for patients taking oral anticoagulants (coumadin or Previscan)]. |
| PubMed: | Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. |
| PubMed: | Varenicline: the newest agent for smoking cessation. |
| PubMed: | Comparison of LionHeart LVAD-implanted calves based on renal infarctions. |
| PubMed: | Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. |
| PubMed: | Rivaroxaban. |
| PubMed: | Evaluation and management of atrial fibrillation. |
| PubMed: | Not only green tea but also green leafy vegetables inhibit warfarin. |
| PubMed: | Safety considerations with omega-3 fatty acid therapy. |
| PubMed: | Relationship between diet and anticoagulant response to warfarin: a factor analysis. |
| PubMed: | Interaction potential between cranberry juice and warfarin. |
| PubMed: | Multiresidue analysis of seven anticoagulant rodenticides by high-performance liquid chromatography/electrospray/mass spectrometry. |
| PubMed: | New antithrombotic agents. |
| PubMed: | Oral varenicline for smoking cessation. |
| PubMed: | Dietary vitamin K intake and anticoagulation in elderly patients. |
| PubMed: | Cranberry does not affect prothrombin time in male subjects on warfarin. |
| PubMed: | Warfarin interaction with herbal drugs and food. |
| PubMed: | Potential applicability and utilization of left atrial appendage occlusion devices in patients with atrial fibrillation. |
| PubMed: | Cranberry and urinary tract infections: slightly fewer episodes in young women, but watch out for interactions. |
| PubMed: | Interaction between warfarin and cranberry juice. |
| PubMed: | Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices. |
| PubMed: | Anticoagulation and inhibition of nitric oxide synthase influence hepatic hypoxia after monocrotaline exposure. |
| PubMed: | Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. |
| PubMed: | The challenges of new drugs benefits and risks analysis: lessons from the ximelagatran FDA Cardiovascular Advisory Committee. |
| PubMed: | Warfarin resistance: interaction between warfarin and Eruca sativa L. |
| PubMed: | [Determination of vitamin K in aojiru (green juice) products by HPLC]. |
| PubMed: | Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. |
| PubMed: | Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement. |
| PubMed: | Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents. |
| PubMed: | [Pharmacogenetics of warfarin]. |
| PubMed: | Dietary supplement and selected food interactions with warfarin. |
| PubMed: | [Interaction between Waran and cranberry juice]. |
| PubMed: | Warfarin and its interactions with foods, herbs and other dietary supplements. |
| PubMed: | Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. |
| PubMed: | Development of a cell culture/ELISA assay to detect anticoagulant rodenticides and its application to analysis of rodenticide treated grain. |
| PubMed: | Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? |
| PubMed: | A spectroscopic study of the interaction of isoflavones with human serum albumin. |
| PubMed: | Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. |
| PubMed: | Trials and tribulations of non-inferiority: the ximelagatran experience. |
| PubMed: | Considerations and challenges with existing treatments for thrombosis in cancer patients. |
| PubMed: | Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. |
| PubMed: | Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections. |
| PubMed: | Atrial fibrillation and stroke: four treatment controversies. |
| PubMed: | An adverse interaction between warfarin and fluoropyrimidines revisited. |
| PubMed: | Possible interaction between warfarin and cranberry juice. |
| PubMed: | Low potential for interactions between melagatran/ximelagatran and other drugs, food, or alcohol. |
| PubMed: | Evolving management strategies for heparin-induced thrombocytopenia. |
| PubMed: | Anticoagulation: new challenges, old drugs. |
| PubMed: | The approach to massive pulmonary embolism. |
| PubMed: | Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements. |
| PubMed: | Clinical pharmacokinetics of losartan. |
| PubMed: | Uncertain times for oral anticoagulation therapy. |
| PubMed: | Comment: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. |
| PubMed: | Systematic overview of warfarin and its drug and food interactions. |
| PubMed: | Efficacy and safety of rosuvastatin in treatment of dyslipidemia. |
| PubMed: | A better way to prevent blood clots? A drug derived from cobra venom offers an alternative to warfarin, although liver problems temper its benefits. |
| PubMed: | Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study. |
| PubMed: | Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. |
| PubMed: | A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. |
| PubMed: | Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose. |
| PubMed: | Preventing stroke in atrial fibrillation: the SPORTIF programme. |
| PubMed: | Capecitabine: a review. |
| PubMed: | Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. |
| PubMed: | Oral anticoagulation: challenges in the case-management setting. |
| PubMed: | What's the scoop with grapefruit? |
| PubMed: | Interaction of warfarin with drugs, natural substances, and foods. |
| PubMed: | Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers. |
| PubMed: | Interaction between Gemcitabine and Warfarin Causing Gastrointestinal Bleeding in a Patient with Pancreatic Cancer. |
| PubMed: | The role of oral direct thrombin inhibitors in atrial fibrillation. |
| PubMed: | Ximelagatran: pharmacology, pharmacokinetics, and pharmacodynamics. |
| PubMed: | New possibilities in anticoagulant management of atrial fibrillation. |
| PubMed: | Changing the guard in long-term anticoagulation: clinical and economic implications. |
| PubMed: | The potential for changing prescribing patterns from warfarin to oral direct thrombin inhibitors: clinical scenarios. |
| PubMed: | Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran. |
| PubMed: | Clinical pharmacology of bosentan, a dual endothelin receptor antagonist. |
| PubMed: | [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins]. |
| PubMed: | Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy. |
| PubMed: | Ximelagatran in prevention of cardiovascular events. |
| PubMed: | New blood thinner offers first potential alternative in 50 years: ximelagatran. |
| PubMed: | Potential interaction between soy milk and warfarin. |
| PubMed: | Ximelagatran: an oral direct thrombin inhibitor. |
| PubMed: | Consistent vitamin K helps warfarin do its job. Food can throw off warfarin's ability to prevent blood clots. Keeping your vitamin K intake relatively constant can help you avoid problems with this medication. |
| PubMed: | Clinical pharmacokinetics of levetiracetam. |
| PubMed: | D-003 and warfarin interaction on the bleeding time and venous thrombosis experimentally induced in rats. |
| PubMed: | [Biological effects of vitamin K and concentration of vitamin K in Norwegian food]. |
| PubMed: | The scoop on green tea. |
| PubMed: | Vitamin K and oral anticoagulation: thought for food. |
| PubMed: | Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. |
| PubMed: | Clinical pharmacokinetics of thalidomide. |
| PubMed: | Of blood, bones, and broccoli: warfarin-vitamin K interactions. |
| PubMed: | Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). |
| PubMed: | Warfarin and cranberry juice: an interaction? |
| PubMed: | Racial and ethnic differences in warfarin response. |
| PubMed: | Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation? |
| PubMed: | Possible interaction between warfarin and cranberry juice. |
| PubMed: | Hyperhomocysteinemia and B-vitamin status after discontinuation of oral anticoagulation therapy in patients with a history of venous thromboembolism. |
| PubMed: | Vitamin K content of nuts and fruits in the US diet. |
| PubMed: | Overview of heparin-induced thrombocytopenia. |
| PubMed: | Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. |
| PubMed: | Oral direct thrombin inhibitors in clinical development. |
| PubMed: | [Vitamin K in food and the effect of warfarin]. |
| PubMed: | The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. |
| PubMed: | Current anticoagulant therapy--unmet clinical needs. |
| PubMed: | Mixing medicines, herbs, food, and surgery. |
| PubMed: | The coagulation system contributes to synergistic liver injury from exposure to monocrotaline and bacterial lipopolysaccharide. |
| PubMed: | New Food and Drug Administration requirements for inclusion of vitamin K in adult parenteral multivitamins. |
| PubMed: | Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. |
| PubMed: | Lopinavir/ritonavir: a review of its use in the management of HIV infection. |
| PubMed: | Pharmacokinetics of selective estrogen receptor modulators. |
| PubMed: | Anticoagulation of pregnant women with mechanical heart valves. |
| PubMed: | Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. |
| PubMed: | Genetic and environmental risk factors for oral anticoagulant overdose. |
| PubMed: | Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy. |
| PubMed: | [Oral anticoagulant treatment: practical aspects and significance of anticoagulant clinics]. |
| PubMed: | Effect of soy milk on warfarin efficacy. |
| PubMed: | Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. |
| PubMed: | Interactions of warfarin. |
| PubMed: | Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity. |
| PubMed: | Enhancement of allyl alcohol hepatotoxicity by endotoxin requires extrahepatic factors. |
| PubMed: | Melatonin for the prevention and treatment of jet lag. |
| PubMed: | Optimizing prophylaxis of venous thromboembolism. |
| PubMed: | Interaction between warfarin and mango fruit. |
| PubMed: | Is low-intensity anticoagulant therapy possible with an open pivot valve?: analysis of its development. |
| PubMed: | Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. |
| PubMed: | Use of alternative pharmacotherapy in management of cardiovascular diseases. |
| PubMed: | Pharmacokinetic profile of zafirlukast. |
| PubMed: | FDA adverse event reports on statin-associated rhabdomyolysis. |
| PubMed: | Adverse events and deaths associated with laboratory errors at a hospital--Pennsylvania, 2001. |
| PubMed: | Seaweed, vitamin K, and warfarin. |
| PubMed: | Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report. |
| PubMed: | FDA warns Merck over its promotion of rofecoxib. |
| PubMed: | Warfarin resistance and enteral feedings: 2 case reports and a supporting in vitro study. |
| PubMed: | [The safety of herbal medicines in the psychiatric practice]. |
| PubMed: | Drug interactions with irbesartan. |
| PubMed: | Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates. |
| PubMed: | Practitioner report involving intravenous use of vitamin K1 prompts label review and revision. |
| PubMed: | Melatonin for preventing and treating jet lag. |
| PubMed: | Clinical pharmacokinetics of capecitabine. |
| PubMed: | Profile of moxifloxacin drug interactions. |
| PubMed: | Subtherapeutic INR values associated with a switch to generic warfarin. |
| PubMed: | Generic substitution: issues for problematic drugs. |
| PubMed: | Development of a self-assessment instrument to determine daily intake and variability of dietary vitamin K. |
| PubMed: | Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. |
| PubMed: | Tests of potential functional barriers for laminated multilayer food packages. Part II: Medium molecular weight permeants. |
| PubMed: | Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use. |
| PubMed: | The interaction between vitamin K nutriture and warfarin administration in patients with bacterial overgrowth due to atrophic gastritis. |
| PubMed: | Dose selection and dosing interval determination for LTRA use in asthma. |
| PubMed: | Assessment of healthcare professionals' knowledge about warfarin-vitamin K drug-nutrient interactions. |
| PubMed: | Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin. |
| PubMed: | Warfarin and celecoxib interaction. |
| PubMed: | [Oral anticoagulants and medicinal plants. An emerging interaction]. |
| PubMed: | Response to warfarin and other oral anticoagulants: effects of disease states. |
| PubMed: | Management of deep venous thrombosis and pulmonary embolism. |
| PubMed: | Workshop: Patient Self-Management: Update of Ongoing Studies in Sweden. |
| PubMed: | Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis. |
| PubMed: | Outpatient management of patients on warfarin. |
| PubMed: | Ciprofloxacin-warfarin coagulopathy: a case series. |
| PubMed: | Cyclodextrin-based optosensor for the determination of warfarin in waters. |
| PubMed: | Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong? |
| PubMed: | Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health. |
| PubMed: | Vitamin K: a practical guide to the dietary management of patients on warfarin. |
| PubMed: | Optimizing anticoagulant therapy in the management of pulmonary embolism. |
| PubMed: | Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: study design and data analysis issues. |
| PubMed: | Vitamin K-supplemented snacks containing olestra: implication for patients taking warfarin. |
| PubMed: | Clinical pharmacokinetics of troglitazone. |
| PubMed: | Hypersensitivity myocarditis associated with ephedra use. |
| PubMed: | Medtronic Freestyle aortic root bioprosthesis: Implant techniques. |
| PubMed: | Clinical aspects of the use of clopidogrel, a new antiplatelet agent. |
| PubMed: | Grapefruit juice might still be factor in warfarin response. |
| PubMed: | Management of narrow therapeutic index drugs. |
| PubMed: | Deep venous thrombosis: early discharge strategies and outpatient management. |
| PubMed: | Isoniazid drug and food interactions. |
| PubMed: | Herbal remedies: adverse effects and drug interactions. |
| PubMed: | Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus--a case report. |
| PubMed: | Protein-calorie malnutrition does not predict subtle vitamin K depletion in hospitalized patients. |
| PubMed: | Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin. |
| PubMed: | Clinical pharmacokinetics of nimesulide. |
| PubMed: | Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions. |
| PubMed: | The antiplatelet effects of ticlopidine and clopidogrel. |
| PubMed: | Grapefruit juice and the response to warfarin. |
| PubMed: | Modern management of prosthetic valve anticoagulation. |
| PubMed: | Azimilide dihydrochloride, a novel antiarrhythmic agent. |
| PubMed: | Pharmacokinetics of grepafloxacin. |
| PubMed: | Clinical pharmacokinetics of nefazodone. |
| PubMed: | Probable interaction between warfarin and ginseng. |
| PubMed: | Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. |
| PubMed: | The clinical pharmacokinetics of levofloxacin. |
| PubMed: | Interventional cardiology and intracoronary stents--a changing practice: approved vs. nonapproved indications. |
| PubMed: | Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic. |
| PubMed: | Warfarin resistance: diagnosis and therapeutic alternatives. |
| PubMed: | Vitamin K status influences brain sulfatide metabolism in young mice and rats. |
| PubMed: | Hail stentors! How the hail do I stop the warfarin? |
| PubMed: | Olestra and the FDA. |
| PubMed: | When discharging patients on coumadin, heed this advice. |
| PubMed: | A review of the clinical pharmacokinetics of meloxicam. |
| PubMed: | HPLC determination of anticoagulant rodenticide residues in animal livers. |
| PubMed: | Development and pharmacology of fluvastatin. |
| PubMed: | Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. |
| PubMed: | [Warfarin therapy and chlorella]. |
| PubMed: | Clinical pharmacokinetics of lansoprazole. |
| PubMed: | Pharmacokinetic development of quinolone antibiotics. |
| PubMed: | Drug-food interactions in clinical practice. |
| PubMed: | Protease inhibitors: where are they now? |
| PubMed: | Overview of the pharmacokinetics of fluvoxamine. |
| PubMed: | Development and pharmacology of fluvastatin. |
| PubMed: | Interactions of warfarin with drugs and food. |
| PubMed: | Clinical pharmacokinetics of pravastatin. |
| PubMed: | Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. |
| PubMed: | Outpatient use of a portable international normalized ratio/prothrombin time monitor. |
| PubMed: | An outbreak of vampire bat bite in a Brazilian village. |
| PubMed: | Accidental poisoning by warfarin-contaminated herbal tea. |
| PubMed: | Benazepril: a new ACE inhibitor. |
| PubMed: | Low molecular weight heparins. An objective overview. |
| PubMed: | Factors that influence therapeutic anticoagulation control. |
| PubMed: | Development of a diet low in vitamin K-1 (phylloquinone). |
| PubMed: | The Carpentier-Edwards pericardial aortic valve: intermediate results. |
| PubMed: | Vancomycin, metronidazole, and tetracyclines. |
| PubMed: | Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management. |
| PubMed: | Clinical toleration and safety of azithromycin. |
| PubMed: | [Oral anticoagulant therapy with special reference to the influence of food and drug interactions]. |
| PubMed: | Adverse reaction reporting of interaction between warfarin and fluoroquinolones. |
| PubMed: | Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin. |
| PubMed: | Anticoagulation instability with life-threatening complication after dietary modification. |
| PubMed: | Reversal of osmolite-warfarin interaction by changing warfarin administration time. |
| PubMed: | Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. |
| PubMed: | Recovery of warfarin from an enteral nutrient formula. |
| PubMed: | Unsuspected source of vitamin K in patients treated with anticoagulants: a case report. |
| PubMed: | Pharmacokinetic characteristics of roxatidine. |
| PubMed: | Propafenone: a new antiarrhythmic agent. |
| PubMed: | Biology, ecology, and control of the vampire bat. |
| PubMed: | An attempted homicide using d-CON rat poison. |
| PubMed: | Clinical pharmacokinetics of ketoconazole. |
| PubMed: | Liquid chromatographic determination of coumarin anticoagulants in tablets: collaborative study. |
| PubMed: | Is the dose of warfarin prescribed by American physicians unnecessarily high? |
| PubMed: | Drug interactions in surgical patients. |
| PubMed: | Maternal toxicity in humans and animals: effects on fetal development and criteria for detection. |
| PubMed: | Drug-food interaction information: a file card for patient education. |
| PubMed: | Warfarin and enteral nutrition products. |
| PubMed: | Metabolism and disposition of buspirone. |
| PubMed: | The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogs. |
| PubMed: | [Resistance to vitamin K antagonists. 6 cases]. |
| PubMed: | On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. |
| PubMed: | [Diagnostic aspects and results of drug therapy in pulmonary thromboembolism]. |
| PubMed: | [Thrombolytic therapy with urokinase in 8 patients with massive pulmonary thromboembolism]. |
| PubMed: | Warfarin resistance linked to enteral nutrition products. |
| PubMed: | Enalapril: a review of human pharmacology. |
| PubMed: | Interactions of analgesics with other drugs. |
| PubMed: | Laboratory tests of seven rodenticides for the control of Meriones shawi. |
| PubMed: | A comparative assessment of efficacy of three anticoagulant rodenticides. |
| PubMed: | Liquid nutrition as a cause of warfarin resistance. |
| PubMed: | Clinical Pharmacokinetics of indomethacin. |
| PubMed: | Acquired warfarin resistance and weight-reducing diet. |
| PubMed: | Warfarin resistance and vitamin K. |
| PubMed: | Institutional pharmacists' guide to complying with PPI regulations. |
| PubMed: | Warfarin dosage and vitamin K in Osmolite. |
| PubMed: | "Resistance" to warfarin due to unrecognized vitamin K supplementation. |
| PubMed: | Problems encountered in protecting stored grain from damage by rodents, birds, insects and mites in England and Wales. |
| PubMed: | Inhibition of the hypoprothrombinemic effect of warfarin (Coumadin) by Ensure Plus, a dietary supplement. |
| PubMed: | The influence of fasting on the disposition of warfarin in rats. |
| PubMed: | Trials of the anticoagulants rodenticide WBA 8119 against confined colonies of warfarin-resistant house mice (Mus musculus L.). |
| PubMed: | Trials of the anticoagulant rodenticide WBA 8119 against confined colonies of warfarin-resistant house mice (Mus musculus L.). |
| PubMed: | Laboratory evaluation of WBA 8119 as a rodenticide for use against warfarin-resistant and non-resistant rats and mice. |
| PubMed: | Some properties of calciferol as a rodenticide. |
| PubMed: | MR-100: an anticoagulant rodenticide. |
| PubMed: | Japanese-restaurant syndrome. |
| PubMed: | Effect of silicones on the absorption of anticoagulant drugs. |
| PubMed: | New rodenticide, 'MR-100', containing a taste enhancer. |